Characteristics | ALL(N = 213) | NIKLAS (N = 188) | IKLAS (N = 25) | P-value |
---|---|---|---|---|
Clinical findings | ||||
 AGE | 61.5 ± 12.2 | 61.43 ± 12.05 | 61.92 ± 13.62 | 0.851 |
 Gender |  |  |  | 0.150 |
  Female | 60 (28.2%) | 56 (29.79%) | 4 (16.00%) |  |
  Male | 153 (71.8%) | 132 (70.21%) | 21 (84.00%) |  |
  Smoke | 30 (14.1%) | 24 (12.77%) | 6 (24.00%) | 0.129 |
  Alcohol | 23 (10.8%) | 18 (9.57%) | 5 (20.00%) | 0.115 |
  DM(Year) | 3.0 (2.0–10.0) | 3.0 (2.0–9.2) | 5.0 (2.0–10.0) | 0.250 |
 Underlying disease | ||||
  Biliary diseases | 46 (21.6%) | 39 (20.74%) | 7 (28.00%) | 0.408 |
  CHD | 19 (8.9%) | 18 (9.57%) | 1 (4.00%) | 0.358 |
  Liver diseases | 16 (7.5%) | 15 (7.98%) | 1 (4.00%) | 0.478 |
Symptom at presentation | ||||
 Body temperature | 38.6 ± 1.1 | 38.62 ± 1.09 | 38.61 ± 1.01 | 0.962 |
 Weakness | 82 (38.5%) | 62 (32.98%) | 20 (80.00%) | < 0.001 |
 Diarrhea | 8 (3.8%) | 5 (2.66%) | 3 (12.00%) | 0.021 |
 Vomiting | 22 (10.3%) | 20 (10.64%) | 2 (8.00%) | 0.684 |
 Abdominal pain | 80 (37.6%) | 72 (38.30%) | 8 (32.00%) | 0.541 |
 Chills | 91 (42.7%) | 78 (41.49%) | 13 (52.00%) | 0.580 |
Admission data | ||||
 SBP | 125.5 ± 18.0 | 125.18 ± 16.93 | 127.72 ± 25.23 | 0.510 |
 DBP | 75.4 ± 10.6 | 75.25 ± 9.87 | 76.92 ± 15.32 | 0.461 |
 GLU | 10.3 ± 3.6 | 10.03 ± 3.38 | 12.67 ± 4.17 |  < 0.001 |
 WBC | 11.6 (8.9–15.4) | 11.6 (8.8–15.1) | 12.5 (9.3–19.4) | 0.055 |
 NE | 9.9 (7.2–13.4) | 9.8 (7.1–13.1) | 10.6 (7.8–17.9) | 0.159 |
 HB | 116.0 (105.0–128.0) | 117.0 (106.8–130.0) | 106.0 (97.0–114.0) |  < 0.001 |
 PLT | 191.0 (119.0–273.0) | 205.0 (124.0–290.0) | 125.0 (51.0–182.0) | 0.003 |
 ALT | 57.0 (35.0–93.0) | 57.0 (35.0–93.0) | 58.0 (27.3–90.9) | 0.509 |
 AST | 40.0 (25.7–78.2) | 39.0 (25.6–73.2) | 52.0 (26.0–113.0) | 0.207 |
 ALP | 155.0 (103.0–240.0) | 146.5 (103.0–240.0) | 184.0 (133.0–239.0) | 0.116 |
 LDH | 221.0 (176.0–299.0) | 219.5 (176.8–289.2) | 265.0 (170.0–343.0) | 0.052 |
 ALB | 29.5 (26.7–33.2) | 29.9 (27.2–33.5) | 27.3 (24.1–29.9) | 0.021 |
 TBIL | 12.9 (8.6–21.4) | 12.6 (8.5–19.8) | 15.8 (9.8–31.1) | 0.013 |
 DBIL | 6.5 (4.2–10.9) | 6.2 (4.0–10.4) | 9.5 (5.6–13.5) | 0.009 |
 IBIL | 5.7 (3.8–9.2) | 5.7 (3.8–8.4) | 5.7 (3.8–11.7) | 0.209 |
 BUN | 5.0 (3.6–7.5) | 4.9 (3.6–7.3) | 5.8 (4.1–9.3) | 0.082 |
 TC | 3.2 (2.6–3.9) | 3.3 (2.7–3.9) | 2.7 (2.2–3.1) | 0.014 |
 TG | 1.4 (1.0–1.9) | 1.4 (1.0–2.0) | 1.3 (1.2–1.8) | 0.755 |
 CRP | 114.0 (69.7–184.6) | 112.5 (69.7–173.4) | 163.0 (72.3–222.4) | 0.019 |
 PT | 13.2 (12.4–14.1) | 13.1 (12.3–13.9) | 13.6 (13.0–15.3) | 0.017 |
 D.DIMER | 2.5 (1.2–4.7) | 2.2 (1.2–4.2) | 4.4 (3.7–8.2) |  < 0.001 |
 MDRO | 13 (6.1%) | 10 (5.32%) | 3 (12.00%) | 0.190 |
 SOFA | 1.3 ± 2.3 | 0.87 ± 1.50 | 4.88 ± 3.66 |  < 0.001 |
Radiologic findings | ||||
 Abscess location |  |  |  | 0.672 |
  Right lobe | 160 (75.1%) | 140 (74.47%) | 20 (80.00%) |  |
  Left lobe | 39 (18.3%) | 36 (19.15%) | 3 (12.00%) |  |
  Both lobes | 14 (6.6%) | 12 (6.38%) | 2 (8.00%) |  |
  Abscess size (cm) | 7.3 ± 2.5 | 7.41 ± 2.59 | 6.81 ± 2.04 | 0.271 |
 No. of abscesses |  |  |  | 0.151 |
  Multiple | 52 (24.4%) | 43 (22.87%) | 9 (36.00%) |  |
  Solitary | 161 (75.6%) | 145 (77.13%) | 16 (64.00%) |  |
Treatment | ||||
 Drainage mode |  |  |  | 0.003 |
  None | 32 (15.0%) | 23 (12.23%) | 9 (36.00%) |  |
  Catheterization | 135 (63.4%) | 120 (63.83%) | 15 (60.00%) |  |
  Puncture | 40 (18.8%) | 40 (21.28%) | 0 (0.00%) |  |
  Surgery | 6 (2.8%) | 5 (2.66%) | 1 (4.00%) |  |